IP6K1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 8.32219999999939E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
7.797600E-01
Normal-vs-Stage2
7.79810000000047E-05
Normal-vs-Stage3
1.007560E-02
Normal-vs-Stage4
1.550230E-01
Stage1-vs-Stage2
2.944200E-01
Stage1-vs-Stage3
1.092970E-01
Stage1-vs-Stage4
5.522200E-01
Stage2-vs-Stage3
1.102810E-01
Stage2-vs-Stage4
6.352600E-01
Stage3-vs-Stage4
9.421700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
4.14029999999954E-05
Normal-vs-AfricanAmerican
1.387440E-01
Normal-vs-Asian
5.041400E-03
Caucasian-vs-AfricanAmerican
7.409600E-01
Caucasian-vs-Asian
6.274800E-01
AfricanAmerican-vs-Asian
4.967800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
4.51420000002756E-06
Normal-vs-Female
3.92350000000263E-05
Male-vs-Female
5.377000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
9.890600E-01
Normal-vs-Age(41-60Yrs)
2.103800E-01
Normal-vs-Age(61-80Yrs)
2.42419999996191E-06
Normal-vs-Age(81-100Yrs)
1.020630E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.379000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.018200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.294980E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.184400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.866000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.941000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
2.6232999994491E-07
Normal-vs-Daily Drinker
2.570300E-04
Normal-vs-Weekly Drinker
6.583800E-02
Normal-vs-Occasional Drinker
6.559200E-03
Normal-vs-Social Drinker
7.756100E-02
Non Drinker-vs-Daily Drinker
1.783420E-01
Non Drinker-vs-Weekly Drinker
1.117700E-02
Non Drinker-vs-Occasional Drinker
2.220800E-01
Non Drinker-vs-Social Drinker
2.169900E-02
Daily Drinker-vs-Weekly Drinker
1.621440E-01
Daily Drinker-vs-Occasional Drinker
9.368800E-01
Daily Drinker-vs-Social Drinker
2.440600E-01
Weekly Drinker-vs-Occasional Drinker
2.833400E-01
Weekly Drinker-vs-Social Drinker
8.859600E-01
Occasional Drinker-vs-Social Drinker
3.682000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
5.459000E-01
Normal-vs-Grade 2
8.353800E-01
Normal-vs-Grade 3
8.693600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.049200E-01
Grade 1-vs-Grade 3
2.562200E-01
Grade 1-vs-Grade 4
5.459000E-01
Grade 2-vs-Grade 3
4.771400E-01
Grade 2-vs-Grade 4
8.353800E-01
Grade 3-vs-Grade 4
8.693600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
1.55567999999828E-05
Normal-vs-NonDiabetic
1.84522999999714E-05
Diabetic-vs-NonDiabetic
4.264800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
4.487600E-02
Normal-vs-NoPancreatitis
1.84688999999016E-05
Pancreatitis-vs-NoPancreatitis
8.078200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
2.599700E-03
Normal-vs-N1
4.40019999999874E-05
N0-vs-N1
3.665400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
4.346400E-02
Normal-vs-TP53-NonMutant
5.990600E-01
TP53-Mutant-vs-TP53-NonMutant
3.917500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap